SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $577,104 | -35.5% | 28,042 | +47.5% | 0.04% | -37.3% |
Q2 2023 | $894,179 | +52.2% | 19,017 | +35.8% | 0.06% | +68.6% |
Q1 2023 | $587,440 | +28.1% | 14,000 | +16.5% | 0.04% | +45.8% |
Q4 2022 | $458,519 | -53.4% | 12,022 | -52.1% | 0.02% | -31.4% |
Q3 2022 | $983,000 | +21.8% | 25,106 | +0.5% | 0.04% | +52.2% |
Q2 2022 | $807,000 | +143.8% | 24,973 | +149.8% | 0.02% | +130.0% |
Q1 2022 | $331,000 | +21.2% | 9,997 | +107.8% | 0.01% | +25.0% |
Q2 2021 | $273,000 | -58.3% | 4,812 | -36.5% | 0.01% | -52.9% |
Q4 2020 | $655,000 | +87.7% | 7,574 | +32.7% | 0.02% | 0.0% |
Q3 2020 | $349,000 | -1.4% | 5,708 | -32.9% | 0.02% | -10.5% |
Q2 2020 | $354,000 | -73.3% | 8,502 | -53.7% | 0.02% | -62.0% |
Q4 2019 | $1,327,000 | -39.0% | 18,381 | +18.5% | 0.05% | -49.0% |
Q3 2019 | $2,176,000 | -8.5% | 15,511 | +19.4% | 0.10% | -16.2% |
Q2 2019 | $2,379,000 | +825.7% | 12,992 | +614.6% | 0.12% | +680.0% |
Q3 2018 | $257,000 | -46.1% | 1,818 | -40.4% | 0.02% | -50.0% |
Q2 2018 | $477,000 | -2.9% | 3,049 | -0.1% | 0.03% | -16.7% |
Q1 2018 | $491,000 | -21.9% | 3,051 | -20.1% | 0.04% | -29.4% |
Q4 2017 | $629,000 | +159.9% | 3,820 | -1.5% | 0.05% | +131.8% |
Q3 2017 | $242,000 | -40.0% | 3,880 | -23.3% | 0.02% | -42.1% |
Q2 2017 | $403,000 | +11.9% | 5,060 | 0.0% | 0.04% | +11.8% |
Q1 2017 | $360,000 | +44.0% | 5,060 | +3.2% | 0.03% | +13.3% |
Q4 2016 | $250,000 | – | 4,901 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |